|
1
|
Gross JL, de Azevedo MJ, Silveiro SP,
Canani LH, Caramori ML and Zelmanovitz T: Diabetic nephropathy:
diagnosis, prevention, and treatment. Diabetes Care. 28:164–176.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rossing P, Rossing K, Gaede P, Pedersen O
and Parving HH: Monitoring kidney function in type 2 diabetic
patients with incipient and overt diabetic nephropathy. Diabetes
Care. 29:1024–1030. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
American Diabetes Association. Standards
of medical care in diabetes - 2011. Diabetes Care. 34(Suppl 1):
S11–S61. 2011.
|
|
4
|
Choudhury D, Tuncel M and Levi M: Diabetic
nephropathy - a multifaceted target of new therapies. Discov Med.
10:406–415. 2010.PubMed/NCBI
|
|
5
|
Moresco RN, Sangoi MB, De Carvalho JA,
Tatsch E and Bochi GV: Diabetic nephropathy: traditional to
proteomic markers. Clin Chim Acta. 421:17–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Booya F, Bandarian F, Larijani B, Pajouhi
M, Nooraei M and Lotfi J: Potential risk factors for diabetic
neuropathy: a case control study. BMC Neurol. 5:242005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Retnakaran R, Cull CA, Thorne KI, Adler AI
and Holman RR; UKPDS Study Group. Risk factors for renal
dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.
Diabetes. 55:1832–1839. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cohen-Bucay A and Viswanathan G: Urinary
markers of glomerular injury in diabetic nephropathy. Int J
Nephrol. 2012:1469872012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim SS, Song SH, Kim IJ, et al: Clinical
implication of urinary tubular markers in the early stage of
nephropathy with type 2 diabetic patients. Diabetes Res Clin Pract.
97:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garg JP and Bakris GL: Microalbuminuria:
marker of vascular dysfunction, risk factor for cardiovascular
disease. Vasc Med. 7:35–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cohen MP, Lautenslager GT and Shearman CW:
Increased collagen IV excretion in diabetes. A marker of
compromised filtration function. Diabetes Care. 24:914–918. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Isakova T, Xie H, Yang W, et al:
Fibroblast growth factor 23 and risks of mortality and end-stage
renal disease in patients with chronic kidney disease. JAMA.
305:2432–2439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Barratt J and Topham P: Urine proteomics:
the present and future of measuring urinary protein components in
disease. CMAJ. 177:361–368. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim SS, Song SH, Kim IJ, et al: Urinary
cystatin C and tubular proteinuria predict progression of diabetic
nephropathy. Diabetes Care. 36:656–661. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Han WK, Wagener G, Zhu Y, Wang S and Lee
HT: Urinary biomarkers in the early detection of acute kidney
injury after cardiac surgery. Clin J Am Soc Nephrol. 4:873–882.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nielsen SE, Reinhard H, Zdunek D, et al:
Tubular markers are associated with decline in kidney function in
proteinuric type 2 diabetic patients. Diabetes Res Clin Pract.
97:71–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liangos O, Perianayagam MC, Vaidya VS, et
al: Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney
injury molecule-1 level are associated with adverse outcomes in
acute renal failure. J Am Soc Nephrol. 18:904–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bennett M, Dent CL, Ma Q, et al: Urine
NGAL predicts severity of acute kidney injury after cardiac
surgery: a prospective study. Clin J Am Soc Nephrol. 3:665–673.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bazzi C, Petrini C, Rizza V, et al:
Urinary N-acetyl-beta-glucosaminidase excretion is a marker of
tubular cell dysfunction and a predictor of outcome in primary
glomerulonephritis. Nephrol Dial Transplant. 17:1890–1896. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mori K and Nakao K: Neutrophil
gelatinase-associated lipocalin as the real-time indicator of
active kidney damage. Kidney Int. 71:967–970. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lim AK and Tesch GH: Inflammation in
diabetic nephropathy. Mediators Inflamm. 2012:1461542012.PubMed/NCBI
|
|
22
|
Navarro JF, Mora C, Maca M and Garca J:
Inflammatory parameters are independently associated with urinary
albumin in type 2 diabetes mellitus. Am J Kidney Dis. 42:53–61.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Misseri R, Meldrum DR, Dinarello CA, et
al: TNF-alpha mediates obstruction-induced renal tubular cell
apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol.
288:F406–F411. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Navarro JF and Mora-Fernández C: The role
of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic
implications. Cytokine Growth Factor Rev. 17:441–450. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma YC, Zuo L, Chen JH, et al: Modified
glomerular filtration rate estimating equation for Chinese patients
with chronic kidney disease. J Am Soc Nephrol. 17:2937–2944. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vaidya VS, Waikar SS, Ferguson MA, et al:
Urinary biomarkers for sensitive and specific detection of acute
kidney injury in humans. Clin Transl Sci. 1:200–208. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Titan SM, Vieira JM Jr, Dominguez WV, et
al: Urinary MCP-1 and RBP: independent predictors of renal outcome
in macroalbuminuric diabetic nephropathy. J Diabetes Complications.
26:546–553. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hong CY, Chia KS and Ling SL: Urinary
protein excretion in Type 2 diabetes with complications. J Diabetes
Complications. 14:259–265. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nakamura A, Shikata K, Hiramatsu M, et al:
Serum interleukin-18 levels are associated with nephropathy and
atherosclerosis in Japanese patients with type 2 diabetes. Diabetes
Care. 28:2890–2895. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deng WJ, Nie S, Dai J, Wu JR and Zeng R:
Proteome, phosphoproteome, and hydroxyproteome of liver
mitochondria in diabetic rats at early pathogenic stages. Mol Cell
Proteomics. 9:100–116. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ben Ameur R, Molina L, Bolvin C, et al:
Proteomic approaches for discovering biomarkers of diabetic
nephropathy. Nephrol Dial Transplant. 25:2866–2875. 2010.PubMed/NCBI
|
|
32
|
Darde VM, Barderas MG and Vivanco F:
Multiple reaction monitoring (MRM) of plasma proteins in
cardiovascular proteomics. Methods Mol Biol. 1000:191–199. 2013.
View Article : Google Scholar : PubMed/NCBI
|
